19 Jul, 2019
Congressional Budget Office Cost Estimate: S. 1416, Affordable Prescriptions for Patients Act of 2019
United States. Congressional Budget Office
This is the Congressional Budget Office Cost Estimate for S. 1416. According to the report, "Estimated budgetary effects would stem from [1] Generic or biosimilar drugs entering the market earlier, on average, than would be the case under current law, resulting in lower federal spending for prescription drugs and subsidies for health insurance."
-
URL
-
Publisher
-
Date19 Jul, 2019
-
CopyrightPublic Domain
-
Retrieved FromCongressional Budget Office: www.cbo.gov/
-
Formatpdf
-
Media Typeapplication/pdf
-
Subjects
-
Resource Group
Details